Further improvement in outcomes of nasopharyngeal carcinoma with optimized radiotherapy and induction plus concomitant chemotherapy: an update of the Milan experience.
about
Meta-analysis of diagnostic value of 18F-FDG PET or PET/CT for detecting lymph node and distant metastases in patients with nasopharyngeal carcinoma.Intensity-modulated radiotherapy with simultaneous modulated accelerated boost technique and chemotherapy in patients with nasopharyngeal carcinoma.Prognostic factors and survival in patients with radiation-related second malignant neoplasms following radiotherapy for nasopharyngeal carcinoma.Correlation between nasopharyngeal carcinoma tumor volume and the 2002 International Union Against Cancer tumor classification systemArterial interventional chemotherapy and IMRT with concurrent chemotherapy for nasopharyngeal carcinoma with intracranial involvement.Nasopharyngeal carcinoma in Slovenia, 1990-2003 (results of treatment with conventional two-dimensional radiotherapy).High FMNL3 expression promotes nasopharyngeal carcinoma cell metastasis: role in TGF-β1-induced epithelia-to-mesenchymal transitionCurrent treatment options for recurrent nasopharyngeal cancer.Locally advanced nasopharyngeal carcinoma: Current and emerging treatment strategies.Critical analysis of locoregional failures following intensity-modulated radiotherapy for nasopharyngeal carcinoma.Tumor Volume Predicts Survival Rate of Advanced Nasopharyngeal Carcinoma Treated with Concurrent Chemoradiotherapy.Prognostic value of tumor volume for patients with nasopharyngeal carcinoma treated with concurrent chemotherapy and intensity-modulated radiotherapy.Prognostic significance of tumor volume in patients with nasopharyngeal carcinoma undergoing intensity-modulated radiation therapy.Simultaneous integrated boost intensity-modulated radiotherapy (SIB‑IMRT) in nasopharyngeal cancer.
P2860
Q34568192-30C85576-5D73-4ADA-AA44-167C93F25DE9Q34788288-14AF4C19-120F-4E27-BD45-3E35D85544C2Q35075815-DAB0DC23-2397-4256-ABCB-38EF177714D8Q36811721-726CC5F8-DE1A-4214-97F5-D6C6797E4640Q37211589-91F8483A-222C-4BE1-A4C2-F509CFCC08CFQ37392152-8D44289B-8216-4D16-A4DC-536A5FC90BA6Q37642739-00D64AA4-65B8-4256-AD59-E11B459525B1Q37791861-51B99274-6378-421D-B85C-ABFCCF99A48EQ37968598-E8557E60-BD0F-4492-A0A6-0430E6B589FFQ39501001-47FCBFF6-7795-4743-8BE9-A8A4B543C28BQ40804251-384F7420-50BB-4880-93FF-0E9593EC80D2Q44250509-56ADDBE5-45E1-4832-B839-9DAC34D339E5Q46377282-0602BB94-3B63-41F8-A7A5-1D7600880FB8Q50438486-699C8751-3C56-40E6-8F42-D5E598404072
P2860
Further improvement in outcomes of nasopharyngeal carcinoma with optimized radiotherapy and induction plus concomitant chemotherapy: an update of the Milan experience.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Further improvement in outcome ...... pdate of the Milan experience.
@en
Further improvement in outcome ...... pdate of the Milan experience.
@nl
type
label
Further improvement in outcome ...... pdate of the Milan experience.
@en
Further improvement in outcome ...... pdate of the Milan experience.
@nl
prefLabel
Further improvement in outcome ...... pdate of the Milan experience.
@en
Further improvement in outcome ...... pdate of the Milan experience.
@nl
P2093
P50
P1476
Further improvement in outcome ...... update of the Milan experience
@en
P2093
Gabriele Scaramellini
Giulio Cantù
Marzia Franceschini
Mauro Palazzi
Paolo Potepan
Patrizia Olmi
Stefano Tomatis
P304
P356
10.1016/J.IJROBP.2008.08.068
P407
P577
2009-02-26T00:00:00Z